Causes of psoriasis - KHSL
Causes of psoriasis KHSL The symptoms of psoriasis (suh-RYE-uh-sihs), like scaling, itching, and redness, are due mainly to the over-production of cells in the skin's outer layer. While a normal skin cell may take a month to mature and be replaced, in a person with psoriasis, ... |
Analyst Picks and Pans: ABT, CTV, AAP, AZO, DPS, PBG, CCE, PAS BusinessWeek He still sees Humira's contribution to profit rising as the drug makes gains as a treatment for psoriasis. Two other drugs, Kaletra and Depakote, together with Humira made up 45% of the company's $16.3 billion in pharmaceutical sales in 2008. ... |
Unraveling psoriasis at a genetic level msnbc.com By Diane Mapes Ethan Crockett’s first outbreak of psoriasis escalated from an itch to a rash to an irrational panic in a matter of hours. “I remember I was a little itchy in the morning and when I got to work I noticed I had little red dots all over my ... |
 HealthNewsDigest.com | Project Runway’s Tim Gunn Launches Addressing Psoriasis™ Campaign HealthNewsDigest.com, NY Dermatologist Susan C. Taylor, MD, and Gunn are working together to encourage people with plaque psoriasis to visit a dermatologist and take the first step in managing their condition. The cornerstone of the campaign is a contest to recognize people ... |
 Lawyers and Settlements | Psoriasis Drug Raptiva May Cause Serious Brain Infection InjuryBoard.com, FL The FDA recently announced that the Psoriasis drug, Raptiva, has been linked to three, and possibly a fourth, cases of Progressive Multifocal Leukoencephalopathy (PML). PML is a brain infection that causes serious neurological problems. ... Psoriasis Drug Raptiva Suspended in Other Countries. Not in US. |
 Genetic Engineering News (press release) | Dermatologic biotech Magen sold to PPD Mass High Tech, USA The buyout will give PPD an inroad into treating psoriasis, atopic dermatitis and acne, as well as the ability to test safety and efficacy of skin therapeutics. Dermatologic treatments generally have a “more straightforward path to regulatory approval ... PPD Sells Research Center for $46M and Picks Up Magen for $14.5M PPD Acquires Magen BioSciences |
Causes of psoriasis KHSL The symptoms of psoriasis (suh-RYE-uh-sihs), like scaling, itching, and redness, are due mainly to the over-production of cells in the skin's outer layer. While a normal skin cell may take a month to mature and be replaced, in a person with psoriasis, ... |
Analyst Picks and Pans: ABT, CTV, AAP, AZO, DPS, PBG, CCE, PAS BusinessWeek He still sees Humira's contribution to profit rising as the drug makes gains as a treatment for psoriasis. Two other drugs, Kaletra and Depakote, together with Humira made up 45% of the company's $16.3 billion in pharmaceutical sales in 2008. ... |
Unraveling psoriasis at a genetic level msnbc.com By Diane Mapes Ethan Crockett’s first outbreak of psoriasis escalated from an itch to a rash to an irrational panic in a matter of hours. “I remember I was a little itchy in the morning and when I got to work I noticed I had little red dots all over my ... |
HealthNewsDigest.com | Project Runway’s Tim Gunn Launches Addressing Psoriasis™ Campaign HealthNewsDigest.com, NY Dermatologist Susan C. Taylor, MD, and Gunn are working together to encourage people with plaque psoriasis to visit a dermatologist and take the first step in managing their condition. The cornerstone of the campaign is a contest to recognize people ... |
Lawyers and Settlements | Psoriasis Drug Raptiva May Cause Serious Brain Infection InjuryBoard.com, FL The FDA recently announced that the Psoriasis drug, Raptiva, has been linked to three, and possibly a fourth, cases of Progressive Multifocal Leukoencephalopathy (PML). PML is a brain infection that causes serious neurological problems. ... Psoriasis Drug Raptiva Suspended in Other Countries. Not in US. |
Genetic Engineering News (press release) | Dermatologic biotech Magen sold to PPD Mass High Tech, USA The buyout will give PPD an inroad into treating psoriasis, atopic dermatitis and acne, as well as the ability to test safety and efficacy of skin therapeutics. Dermatologic treatments generally have a “more straightforward path to regulatory approval ... PPD Sells Research Center for $46M and Picks Up Magen for $14.5M PPD Acquires Magen BioSciences |
